Gena Pharmaceuticals Limited

Gena Pharmaceuticals Limited - pharma in Kolkata, West Bengal, India. FY 2026 financials & compliance.
CIN U24239WB2004PLC098504 Incorporated 11 May 2004 ROC Kolkata HQ Kolkata, West Bengal, India
Under Liquidation Public Limited Company pharma
Data last updated
Revenue · FY 2020
₹7.07 Cr
▼ 30% YoY
Net loss · FY 2020
₹25.61 Lakh
Net margin -3.6%
EBITDA · FY 2020
₹34.6 Lakh
EBITDA margin 4.9%
Authorised capital
₹3 Cr
Registered with MCA
Paid-up capital
₹2.87 Cr
Issued & subscribed
Open charges
₹32.29 Cr
Satisfied ₹11.54 Cr
Company age
22 yrs
Est. 2004
Employees · EPFO
32
Provident fund records

About Gena Pharmaceuticals Limited

Data last updated:

Gena Pharmaceuticals Limited is a public limited company based in Kolkata, West Bengal, India. The company is currently under liquidation, meaning its assets are being sold to settle outstanding debts. It may not have the legal capacity to fulfil new contracts. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 May 2004.

The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24239WB2004PLC098504. Its GSTIN is 19AACCG2449Q1Z1 (West Bengal).

The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹2.87 Cr. It is led by directors including Vijaykumar Kanoria and Suresh Kumar Sharma.

Its last annual general meeting (AGM) was held on 28 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at 7/2/1 Thakurpukur (N/W) Road P.S Barasat, Kolkata, West Bengal, India – 700128.

As per the financials filed for FY 2020, the company reported a revenue of ₹7.07 Cr, a decline of 30% compared to the previous year. For the same year it recorded a net loss of ₹25.61 Lakh (net margin -3.6%) and EBITDA of ₹34.6 Lakh (EBITDA margin 4.9%). Revenue has declined at a compounded annual rate (CAGR) of 31% over three years and 16% over five years.

The company has about 32 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹32.29 Cr and satisfied charges of ₹11.54 Cr on record. Court records list 56 cases involving the company, including 29 filed by the company and 27 filed against it; 12 cases are pending.

The last known website on record is ipgenapharma.com.

Company details

CIN U24239WB2004PLC098504
Registration Number 098504
Incorporation Date 11 May 2004
ROC Kolkata
Listing Status Unlisted
Company Status Under Liquidation
Date of Last AGM 28 December 2020
Date of Balance Sheet 31 March 2020
Compliance Status Active Non-Compliant

CIN history

Gena Pharmaceuticals has one previous CIN (Corporate Identification Number): U24239WB2004PTC098504. The current CIN is U24239WB2004PLC098504, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24239WB2004PLC098504Current
U24239WB2004PTC098504Previous

Contact details

Gena Pharmaceuticals Limited's registered office is in Kolkata, West Bengal. Its website is ipgenapharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    7/2/1 Thakurpukur (N/W) Road P.S Barasat, Kolkata, West Bengal, India – 700128
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Gena Pharmaceuticals Limited, buy the company report.

Comprehensive company report
Gena Pharmaceuticals Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Gena Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Gena Pharmaceuticals Limited, buy the company report.

Financials of Gena Pharmaceuticals Limited

FY 2020 filings available

Gena Pharmaceuticals Limited reported revenue of ₹7.07 Cr (down 30% YoY) for FY 2020.

Revenue · FY 2020
₹7.07 Cr ▼ 30%
Net loss · FY 2020
₹25.61 Lakh margin -3.6%
EBITDA · FY 2020
₹34.6 Lakh margin 4.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 30%
3 years · compounded
▼ 31%
5 years · compounded
▼ 16%
EBITDA CAGR growth
1 year
▼ 13%
3 years · compounded
▼ 29%
5 years · compounded
▼ 12%

Revenue has declined at a compounded annual rate (CAGR) of 16% over five years, including a 30% fall in the latest year. EBITDA fell 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2019-20FY 2018-19FY 2017-18FY 2016-17FY 2015-16
Profit and Loss Statement
Revenue from Operations₹7.07 Cr
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹34.6 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹25.61 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2019-20FY 2018-19FY 2017-18FY 2016-17FY 2015-16
Profitability
EBITDA Margin4.9%
Net Profit Margin-3.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Gena Pharmaceuticals Limited, buy the company report.

Board of directors of Gena Pharmaceuticals Limited

Gena Pharmaceuticals has 6 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.

Directors (as last reported)
NameDesignationAppointment DateTenureStatus
Suresh Kumar SharmaAdditional Director16 Dec 20223 Years 10 MonthsAs last reported
Arabind Kumar MishraAdditional Director30 Sep 201115 Years 0 MonthsAs last reported
Vijaykumar KanoriaDirector23 May 201214 Years 5 MonthsAs last reported
Abhishek Kumar ShuklaAdditional Director04 Jun 20197 Years 4 MonthsAs last reported
Santosh Kumar SharmaAdditional Director16 Dec 20223 Years 10 MonthsAs last reported
Rintu BhattacharjeeAdditional Director16 Dec 20223 Years 10 MonthsAs last reported

Auditor

Gena Pharmaceuticals Limited is audited by R.LAHIRI & CO for the financial year 2020.

Auditor firmFinancial yearFirm registration number
R.LAHIRI & COFY 2020302024E

Shareholding

The shareholding of Gena Pharmaceuticals Limited is on record for 4 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2019FY 2018FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Gena Pharmaceuticals Limited, buy the company report.

Charges & borrowings

Open charges
₹32.29 Cr
Satisfied charges
₹11.54 Cr
Breakdown by lending institutions
Edelweiss Asset Reconstruction Company Limited₹25.31 Cr
Andhra Bank₹6.98 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
04 Oct 200810129089Edelweiss Asset Reconstruction Company Limited₹12.66 CrOpen
28 Aug 200810123311Edelweiss Asset Reconstruction Company Limited₹12.66 CrOpen
03 Aug 200710077234Andhra Bank₹6.98 CrOpen
26 Oct 200490256479United Bank of India₹11.54 CrSatisfied

To see the full charge records of Gena Pharmaceuticals Limited, buy the company report.

Total charge records: 4 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Gena Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Gena Pharmaceuticals Limited has a workforce of 32 employees on its EPFO records as of Jan 15, 2025, across 1 active EPFO establishment.

Employee count
32
Active EPFO establishments
1
Employee growth
45.45%

GST

Gena Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
19AACCG2449Q1Z1West BengalActive01 Jul 2017

To see the full GST registrations and return filing status of Gena Pharmaceuticals Limited, buy the company report.

Recent activity

Gena Pharmaceuticals Limited has 11 board changes on record since 2011: 6 appointments and 5 cessations. The latest: Rintu Bhattacharjee was appointed as Additional Director on 16 Dec 2022.

Appointed
Rintu Bhattacharjee was appointed as Additional Director.
Appointed
Santosh Kumar Sharma was appointed as Additional Director.
Appointed
Suresh Kumar Sharma was appointed as Additional Director.
AGM
Gena Pharmaceuticals Limited last Annual general meeting of members was held on 28 Dec 2020 as per latest MCA records.
Filing
Gena Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Kolkata.
Ceased
Vijaykumar Kanoria ceased to be Director.
Appointed
Abhishek Kumar Shukla was appointed as Additional Director.
Ceased
Raj Kamal Kanoria ceased to be Additional Director.
Charges
A charge with Edelweiss Asset Reconstruction Company Limited of Rs. 12.66 Cr registered on 04 Oct 2008 with Charge ID 10129089 was modified on 26 Mar 2014.
Charges
A charge with Edelweiss Asset Reconstruction Company Limited of Rs. 12.66 Cr registered on 28 Aug 2008 with Charge ID 10123311 was modified on 26 Mar 2014.
Ceased
Bhola Nath Nandi ceased to be Additional Director.
Appointed
Vijaykumar Kanoria was appointed as Director.

11 earlier events are in the company report.

Frequently asked questions

Gena Pharmaceuticals is currently "Under Liquidation" as per MCA records. The company's assets are being sold to settle outstanding debts owed to creditors. A company under liquidation may not have the legal capacity to fulfil new contracts, and creditors are prioritised in the distribution of proceeds. This is a high-risk status - caution is strongly advised.

Gena Pharmaceuticals is a company under liquidation, formerly operating as a public limited company based in Kolkata, West Bengal, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 May 2004 and is registered under CIN U24239WB2004PLC098504. Caution is advised - the company may not have the legal capacity to fulfil new agreements.

Gena Pharmaceuticals has 6 current directors:

The latest financial statements of Gena Pharmaceuticals on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 28 December 2020. Year-wise statements from 2015 are in the company report.

The CIN (Corporate Identification Number) of Gena Pharmaceuticals is U24239WB2004PLC098504. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Gena Pharmaceuticals has open charges of ₹32.29 Cr and satisfied charges of ₹11.54 Cr as per latest MCA filings.

Gena Pharmaceuticals has 56 court cases on record: 29 filed by the company and 27 filed against it. 12 are pending. Most are in the district courts.

Gena Pharmaceuticals was incorporated on 11 May 2004. It is registered with the Registrar of Companies, Kolkata.

Rintu Bhattacharjee was appointed as Additional Director on 16 Dec 2022. Santosh Kumar Sharma was appointed as Additional Director on 16 Dec 2022. Suresh Kumar Sharma was appointed as Additional Director on 16 Dec 2022. Gena Pharmaceuticals has 11 board changes on record in total.

Gena Pharmaceuticals can be reached through the website ipgenapharma.com. Its registered office is in Kolkata, West Bengal, India.